ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Francesco Leo
Lorenzo Spaggiari
Ugo Pastorino
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Leo, F.
Right arrow Articles by Pastorino, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Leo, F.
Right arrow Articles by Pastorino, U.
Related Collections
Right arrow Lung - cancer

Ann Thorac Surg 2004;77:260-265
© 2004 The Society of Thoracic Surgeons

Original article: general thoracic

Respiratory function changes after chemotherapy: an additional risk for postoperative respiratory complications?

Francesco Leo, MD*a, Piergiorgio Solli, MDa, Lorenzo Spaggiari, MD, PhDa, Giulia Veronesi, MDa, Filippo de Braud, MDb, Maria Elena Leon, MPH, ScDc, Ugo Pastorino, MDa

a Department of Thoracic Surgery, Milan, Italy
b Department of Oncology, Milan, Italy
c Division of Epidemiology and Biostatistics, European Institute of Oncology, Milan, Italy

Accepted for publication July 30, 2003.

* Address reprint requests to Dr Leo, Service de Chirurgie Thoracique, Hopital Pasteur–Pavillon H, 30 Ave de la Voie, Romaine 06002 Nice, France
e-mail: francescoleo{at}interfree.it

BACKGROUND: Patients receiving chemotherapy for lung cancer usually modify their lung function during treatment with increases in forced expiratory volume in 1 second (FEV1) and forced vital capacity (FVC) and decreases in lung diffusion for carbon monoxide (DLCO). This prospective study was designed to evaluate functional changes in forced expiratory volume in 1 second, forced vital capacity, and DLCO after three courses of induction chemotherapy with cisplatinum and gemcitabine in stage IIIa lung cancer patients and to assess their impact on respiratory complications after lung resection.

METHODS: From March 1998 to January 2001, 30 consecutive patients with N2 nonsmall cell lung cancer had surgical resection after neoadjuvant treatment. Pre-chemotherapy and postchemotherapy results of standard respiratory function tests and DLCO were compared in patients with and without postoperative respiratory complications.

RESULTS: All 30 patients completed the chemotherapy protocol without respiratory complications. Significant improvements (p < 0.05) were recorded after chemotherapy in transition dyspnea score, PaO2 (mean value from 79.8 to 86.4 mm Hg), forced expiratory volume in 1 second % (from 78.1% to 87.5%) and forced vital capacity % (from 88.1% to 103.3%). Lung diffusion for carbon monoxide was significantly impaired after chemotherapy (from 74.1% to 65.7%; p = 0.0006), as well as DLCO adjusted for alveolar volume (from 92.8% to 77.4%; p < 0.0001). One patient died after surgery and 4 patients (13.3%) experienced postoperative respiratory complications. Compared with patients without complications, these 4 patients had higher mean increase in FEV1 after chemotherapy (+26.8% vs + 6.7%; p = 0.025), but greater mean decrease in DLCO/Va (-27.8% vs -13.6%; p = 0.03). Impact of change in DLCO on postoperative respiratory complications was not confirmed by multiple logistic regression analysis (p = 0.16).

CONCLUSIONS: In lung cancer patients, forced expiratory volume in 1 second and forced vital capacity assessed after neoadjuvant chemotherapy are not reliable indicators of the likelihood of respiratory complications after surgery. The risk of respiratory complication may be directly linked to loss of DLCO/Va. Lung diffusion for carbon monoxide assessed after neoadjuvant chemotherapy is probably the most sensitive risk indicator of respiratory complications after surgery. We recommend that DLCO studies be performed before and after chemotherapy in lung cancer patients undergoing induction therapy.




This article has been cited by other articles:


Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
W. K. Bernstein and S. Deshpande
Preoperative Evaluation for Thoracic Surgery
Seminars in Cardiothoracic and Vascular Anesthesia, June 1, 2008; 12(2): 109 - 121.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
A. Borri, F. Leo, G. Veronesi, P. Solli, D. Galetta, R. Gasparri, F. Petrella, P. Scanagatta, D. Radice, and L. Spaggiari
Extended pneumonectomy for non-small cell lung cancer: morbidity, mortality, and long-term results.
J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1266 - 1272.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
G. L. Colice, S. Shafazand, J. P. Griffin, R. Keenan, and C. T. Bolliger
Physiologic Evaluation of the Patient With Lung Cancer Being Considered for Resectional Surgery: ACCP Evidenced-Based Clinical Practice Guidelines (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 161S - 177S.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
J. Rubins, M. Unger, and G. L. Colice
Follow-up and Surveillance of the Lung Cancer Patient Following Curative Intent Therapy: ACCP Evidence-Based Clinical Practice Guideline (2nd Edition)
Chest, September 1, 2007; 132(3_suppl): 355S - 367S.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Brunelli, L. Socci, M. Refai, M. Salati, F. Xiume, and A. Sabbatini
Quality of Life Before and After Major Lung Resection for Lung Cancer: A Prospective Follow-Up Analysis
Ann. Thorac. Surg., August 1, 2007; 84(2): 410 - 416.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Leo, P. Scanagatta, P. Baglio, D. Radice, G. Veronesi, P. Solli, F. Petrella, and L. Spaggiari
The risk of pneumonectomy over the age of 70.: A case-control study
Eur. J. Cardiothorac. Surg., May 1, 2007; 31(5): 779 - 782.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
F. Venuta, M. Anile, D. Diso, M. Ibrahim, T. De Giacomo, M. Rolla, V. Liparulo, and G. F. Coloni
Operative complications and early mortality after induction therapy for lung cancer
Eur. J. Cardiothorac. Surg., April 1, 2007; 31(4): 714 - 717.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Brunelli, M. Refai, M. Salati, F. Xiume, and A. Sabbatini
Predicted Versus Observed FEV1 and DLCO After Major Lung Resection: A Prospective Evaluation at Different Postoperative Periods
Ann. Thorac. Surg., March 1, 2007; 83(3): 1134 - 1139.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. Brunelli, F. Xiume, M. Refai, M. Salati, R. Marasco, V. Sciarra, and A. Sabbatini
Evaluation of Expiratory Volume, Diffusion Capacity, and Exercise Tolerance Following Major Lung Resection: A Prospective Follow-up Analysis
Chest, January 1, 2007; 131(1): 141 - 147.
[Abstract] [Full Text] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
F. Leo, P. Solli, G. Veronesi, D. Radice, A. Floridi, R. Gasparri, F. Petrella, A. Borri, D. Galetta, and L. Spaggiari
Does chemotherapy increase the risk of respiratory complications after pneumonectomy?
J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 519 - 523.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
P. Slinger
Pro: low tidal volume is indicated during one-lung ventilation.
Anesth. Analg., August 1, 2006; 103(2): 268 - 270.
[Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
S.-i. Takeda, Y. Funakoshi, Y. Kadota, M. Koma, H. Maeda, S. Kawamura, and Y. Matsubara
Fall in diffusing capacity associated with induction therapy for lung cancer: a predictor of postoperative complication?
Ann. Thorac. Surg., July 1, 2006; 82(1): 232 - 236.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
A. Brunelli, F. Xiume', M. Al Refai, M. Salati, R. Marasco, and A. Sabbatini
Gemcitabine-Cisplatin Chemotherapy Before Lung Resection: A Case-Matched Analysis of Early Outcome
Ann. Thorac. Surg., June 1, 2006; 81(6): 1963 - 1968.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
F. Leo, A. Borri, F. Petrella, R. Gasparri, D. Galetta, G. Veronesi, and L. Spaggiari
Preoperative Chemotherapy and Postoperative Complications: A Closer Look
Ann. Thorac. Surg., June 1, 2006; 81(6): 2335 - 2335.
[Full Text] [PDF]

Home page
 ChestHome page
H. Sugimura and P. Yang
Long-term Survivorship in Lung Cancer: A Review.
Chest, April 1, 2006; 129(4): 1088 - 1097.
[Abstract] [Full Text] [PDF]

Home page
 Ann. Thorac. Surg.Home page
T. Shiraishi, K. Kawahara, T. Shirakusa, S. Yamamoto, and T. Maekawa
Risk Analysis in Resection of Thoracic Esophageal Cancer in the Era of Endoscopic Surgery.
Ann. Thorac. Surg., March 1, 2006; 81(3): 1083 - 1089.
[Abstract] [Full Text] [PDF]

Home page
 MMCTSHome page
P. Lauwers, J. Hendriks, and P. Van Schil
Lobectomy of the right lower lobe for lung cancer
MMCTS, June 28, 2005; 2005(0628): 59.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. J. Stewart, A. E. Martin-Ucar, J. G. Edwards, K. West, and D. A. Waller
Extra-pleural pneumonectomy for malignant pleural mesothelioma: the risks of induction chemotherapy, right-sided procedures and prolonged operations
Eur. J. Cardiothorac. Surg., March 1, 2005; 27(3): 373 - 378.
[Abstract] [Full Text] [PDF]

Home page
 SEMIN CARDIOTHORAC VASC ANESTHHome page
K. P. Grichnik and T. A. D'Amico
Acute Lung Injury and Acute Respiratory Distress Syndrome After Pulmonary Resection
Seminars in Cardiothoracic and Vascular Anesthesia, December 1, 2004; 8(4): 317 - 334.
[Abstract] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2004 by The Society of Thoracic Surgeons.